Solasia Pharma K.K.
4597 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区芝公園二丁目１１番１号
- Website:
- https://solasia.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Solasia Pharma K.K. is a Japanese biopharmaceutical company dedicated to addressing unmet medical needs in oncology. Focused on developing innovative treatments, Solasia aims to give hope to patients facing cancer by listening to their needs and leveraging its expertise in drug development. The company specializes in creating pharmaceuticals for conditions such as chemotherapy-induced nausea and vomiting, peripheral T-cell lymphoma, and oral mucositis. With a nimble, elite team, Solasia is capable of quick decision-making and flexible responses, enabling it to tackle complex challenges often overlooked by larger organizations. Committed to improving patient outcomes, Solasia Pharma strives to create new value in the fight against cancer.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-31 08:49 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 147.2 KB | |
| 2025-03-31 08:43 |
Inside Information Statement
臨時報告書
|
Japanese | 23.8 KB | |
| 2025-03-26 07:30 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 181.4 KB | |
| 2025-03-26 07:21 |
Internal Control over Financial Reporting
内部統制報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 22.7 KB | |
| 2025-03-26 07:20 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-03-26 07:19 |
Annual Report
有価証券報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 1.1 MB | |
| 2025-03-24 07:37 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 263.8 KB | |
| 2025-03-10 07:31 |
Inside Information Statement
臨時報告書
|
Japanese | 19.5 KB | |
| 2024-08-14 08:43 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-08-14 08:42 |
Interim Report
半期報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 238.4 KB | |
| 2024-05-15 08:42 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-05-15 08:40 |
Quarterly Report
四半期報告書－第17期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 219.9 KB | |
| 2024-03-26 07:08 |
Inside Information Statement
臨時報告書
|
Japanese | 22.8 KB | |
| 2024-03-22 07:16 |
Internal Control over Financial Reporting
内部統制報告書－第16期(2023/01/01－2023/12/31)
|
Japanese | 22.7 KB | |
| 2024-03-22 07:15 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
| BrightPath Biotherapeutics Co., Ltd. | Japan | 4594 | ||
|
Calliditas Therapeutics | Sweden | CALTX | |
|
Camurus | Sweden | CAMX | |
| CanBas Co.,Ltd. | Japan | 4575 | ||
|
Cannabotech Ltd. | Israel | CNTC |